Brief: Orthocell Says US Section 232 Tariffs Not Expected To Affect Remplir
08/04/2026 24:54
April 8 (Reuters) - Orthocell Ltd OCC.AX: US SECTION 232 TARIFFS NOT EXPECTED TO AFFECT REMPLIR Further company coverage: OCC.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orthocell
See all newsBrief: Orthocell Reports September Quarter Revenue Of A$3.6 Million
Australia's Orthocell rises as flagship product records first Thailand sales
Brief: Orthocell Says QTRLY A$3.2 Million Revenue Achieved
Australia's Orthocell set for best week since November 2024 on US DoD approval for key product
Brief: Orthocell's First Surgical Use Of Remplir In US Department Of Defense